Cargando…
Molecular Targeted Drugs and Biomarkers in NSCLC, the Evolving Role of Individualized Therapy
Lung cancer first line treatment has been directed from the non-specific cytotoxic doublet chemotherapy to the molecular targeted. The major limitation of the targeted therapies still remains the small number of patients positive to gene mutations. Furthermore, the differentiation between second lin...
Autores principales: | Domvri, Kalliopi, Zarogoulidis, Paul, Darwiche, Kaid, Browning, Robert F., Li, Qiang, Turner, J. Francis, Kioumis, Ioannis, Spyratos, Dionysios, Porpodis, Konstantinos, Papaiwannou, Antonis, Tsiouda, Theodora, Freitag, Lutz, Zarogoulidis, Konstantinos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3842443/ https://www.ncbi.nlm.nih.gov/pubmed/24312144 http://dx.doi.org/10.7150/jca.7734 |
Ejemplares similares
-
Vitamin D in asthma and future perspectives
por: Huang, Haidong, et al.
Publicado: (2013) -
Clinical differences between H3N2 and H1N1 influenza 2012 and lower respiratory tract infection found using a statistical classification approach
por: Petridis, Dimitris, et al.
Publicado: (2014) -
Attitudes of asthmatic and nonasthmatic children to physical exercise
por: Dimitrakaki, Vithleem, et al.
Publicado: (2013) -
Defining the Role of Tyrosine Kinase Inhibitors in Early Stage Non-Small Cell Lung Cancer
por: Lampaki, Sofia, et al.
Publicado: (2015) -
Clinical experimentation with aerosol antibiotics: current and future methods of administration
por: Zarogoulidis, Paul, et al.
Publicado: (2013)